• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 21, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

3-D printing with living tissues may help treat joint diseases

Bioengineer by Bioengineer
June 26, 2017
in Health
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Degeneration of cartilage and other joint tissues is a major cause of disability. A new review highlights the recent developments in biofabrication, a new technique that allows investigators to print living tissues for implantation that can potentially regenerate cartilage and eventually the full joint.

The review also notes that biofabrication can use digital medical images as blueprints for printing patient-specific implants.

"Biofabrication allows for the generation of complex living structures and opens new doors in the treatment of joint damage" said Dr. Jos Malda, senior author of the Journal of Orthopaedic Research study.

###

Media Contact

Penny Smith
[email protected]

http://newsroom.wiley.com/

http://dx.doi.org/10.1002/jor.23602

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Study reveals clonal diversity among CCR8-positive regulatory T cells in human cancer

August 21, 2026

Study explores hope among parents after infants leave neonatal intensive care

August 21, 2026

US Adults’ Progression from Preclinical to Clinical Obesity: Incidence and Risk Factors

August 21, 2026

China’s Hypertensive Patients Face Plan-Related Inequalities in Costs, Disease Progression and Mortality

August 21, 2026
Please login to join discussion

POPULAR NEWS

  • Study reveals clonal diversity among CCR8-positive regulatory T cells in human cancer

    29 shares
    Share 12 Tweet 7
  • Study explores hope among parents after infants leave neonatal intensive care

    29 shares
    Share 12 Tweet 7
  • US Adults’ Progression from Preclinical to Clinical Obesity: Incidence and Risk Factors

    29 shares
    Share 12 Tweet 7
  • Dual-gain color-NIR chip enables fluorescence-guided lung and breast cancer surgery

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Study reveals clonal diversity among CCR8-positive regulatory T cells in human cancer

Study explores hope among parents after infants leave neonatal intensive care

US Adults’ Progression from Preclinical to Clinical Obesity: Incidence and Risk Factors

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.